Common Equity: The sum of all common equity items.
aTyr Pharma, Inc. (ATYR) had Common Equity of $57.74M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-10.79M |
|
-- |
|
-- |
|
$11.44M |
|
$-11.44M |
|
$0.64M |
|
$-10.79M |
|
$-10.79M |
|
$-10.79M |
|
$-10.79M |
|
$-10.79M |
|
$-10.79M |
|
$-11.44M |
|
$-11.30M |
|
98.04M |
|
98.04M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$67.58M |
|
$4.24M |
|
$12.08M |
|
$79.65M |
|
$11.70M |
|
$0.15M |
|
$10.21M |
|
$21.91M |
|
|
Common Equity |
$57.74M |
$57.74M |
|
$57.74M |
|
98.05M |
|
| Cash Flow Statement Financials | |
$-12.52M |
|
$11.49M |
|
$-0.14M |
|
$12.98M |
|
$11.81M |
|
$-1.17M |
|
$1.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.78 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.69% |
|
-18.69% |
|
-13.55% |
|
-18.64% |
|
$0.59 |
|
$-0.13 |
|
$-0.13 |
|